Skip to content
← Back to this collection

PUBLICATIONS · 36961983

Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 May 20
First author
Tannock IF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Nov 10;41(32):4973-4975. doi: 10.1200/JCO.23.01442.
    note
    Source null
    related pmid
    37733978
    relationship
    Comment in

Authors and identifiers

  1. name
    Tannock IF
    type
    Author
  2. name
    Goldstein DA
    type
    Author
  3. name
    Ofer J
    type
    Author
  4. name
    Gyawali B
    type
    Author
  5. name
    Meirson T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tannock IF
    type
    Author
  2. name
    Goldstein DA
    type
    Author
  3. name
    Ofer J
    type
    Author
  4. name
    Gyawali B
    type
    Author
  5. name
    Meirson T
    type
    Author
bibliography ids
  1. nci-bib-748ed39287474ffcdc93a69b
book metadata
content sha256
957db8fd8e0dfd79daeced1ad42105f7f2065236c328af033ff089f45f56423b
document type
citation
dois
  1. 10.1200/JCO.23.00280
electronic publication date
display
2023 Mar 24
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:36961983
immutable id
pubmed:36961983@957db8fd8e0dfd79daeced1ad42105f7f2065236c328af033ff089f45f56423b
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
15
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2713-2717
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2023 Nov 10;41(32):4973-4975. doi: 10.1200/JCO.23.01442.
    note
    Source null
    related pmid
    37733978
    relationship
    Comment in
outcomes validated
false
pmid
36961983
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
04d4b79f9b473204071558f894cd3f8fcb572c5ee135dc59c5f2aeacba6f9d32
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 May 20
precision
day
year
2023
publication types
  1. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36961983/
title
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?

Preserved source evidence · Not medical advice